Clinical Trials on Recurrent Solid Tumors in Netherlands
Total 858 results
-
The Netherlands Cancer InstituteAgenus Inc.RecruitingResectable MMR-deficient Solid Tumors | Resectable MMR-proficient Solid TumorsNetherlands
-
Amsterdam UMC, location VUmcRecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain TumorNetherlands
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Amsterdam UMC, location VUmcCompleted
-
Galapagos NVCompletedSolid TumorsNetherlands
-
Alaunos TherapeuticsCompleted
-
Eli Lilly and CompanyCompletedSolid TumorsNetherlands
-
AstraZenecaTerminated
-
Eisai Inc.Completed
-
Amsterdam UMC, location VUmcCompletedCancer | Advanced Solid TumorsNetherlands
-
PfizerCompletedNeoplasms | Solid TumorsNetherlands, Germany
-
Clavis PharmaCompletedSolid TumorsNetherlands, Belgium
-
University Medical Center GroningenActive, not recruiting
-
Debiopharm International SARecruitingAdvanced Solid TumorsNetherlands, Spain
-
Modra PharmaceuticalsWithdrawn
-
University Medical Center GroningenRecruiting
-
University Medical Center GroningenRegeneron PharmaceuticalsActive, not recruiting
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompleted
-
Chroma TherapeuticsCompleted
-
Amsterdam UMC, location VUmcCristal TherapeuticsCompleted
-
Radboud University Medical CenterCATO-SMSRecruitingAdvanced Solid TumorNetherlands
-
Eisai Inc.Completed
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Netherlands
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyRecruitingAdvanced Solid TumorNetherlands
-
Erasmus Medical CenterNot yet recruitingSolid Tumor, AdultNetherlands
-
GE HealthcareRecruitingOncology | Malignant Solid TumorNetherlands
-
Clovis Oncology, Inc.CompletedAdvanced Solid TumorNetherlands
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Hoffmann-La RocheCompletedSolid TumorUnited Kingdom, Netherlands
-
GlaxoSmithKlineCompletedSolid TumoursUnited States, Netherlands
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
UMC UtrechtCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
AstraZenecaCompletedSolid TumoursNetherlands, Belgium
-
The Netherlands Cancer InstitutePfizerUnknownMalignant Solid TumourNetherlands
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom
-
InteRNATerminatedSolid TumorNetherlands, Belgium
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Maastricht Radiation OncologyCompleted
-
Byondis B.V.RecruitingSolid TumorBelgium, Italy, Netherlands, United Kingdom
-
Radboud University Medical CenterBayerCompletedAdvanced Solid Tumor | Refractory to Standard TherapiesNetherlands
-
Novartis PharmaceuticalsCompletedSolid TumorsNetherlands, Spain, United Kingdom, United States, Belgium
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Maastricht Radiation OncologyWithdrawnHead and Neck Neoplasms | Solid TumorsNetherlands
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
AstraZenecaCompletedSolid TumoursBelgium, United Kingdom, Netherlands
-
Hoffmann-La RocheRecruitingSolid TumorsBelgium, Denmark, Spain, Canada, Netherlands, Poland
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Netherlands, Denmark, Spain, Canada, France
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificBelgium, Netherlands